Reckitt Benckiser Group (OTCMKTS:RBGLY) Raised to “Hold” at Zacks Research

Reckitt Benckiser Group (OTCMKTS:RBGLY) was upgraded by research analysts at Zacks Research to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

RBGLY has been the subject of several other research reports. Citigroup started coverage on Reckitt Benckiser Group in a research report on Wednesday, January 14th. They issued a “buy” rating for the company. Jefferies Financial Group reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a report on Wednesday, January 7th. Morgan Stanley cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Monday, December 15th. Barclays upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 1st. Finally, Royal Bank Of Canada lowered shares of Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research note on Wednesday, January 14th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Reckitt Benckiser Group presently has an average rating of “Moderate Buy”.

Reckitt Benckiser Group Trading Down 5.3%

OTCMKTS:RBGLY traded down $0.86 during mid-day trading on Tuesday, reaching $15.39. The stock had a trading volume of 504,232 shares, compared to its average volume of 366,528. The company has a quick ratio of 0.37, a current ratio of 0.56 and a debt-to-equity ratio of 1.01. Reckitt Benckiser Group has a 1-year low of $12.49 and a 1-year high of $17.80. The stock’s 50 day simple moving average is $16.81 and its two-hundred day simple moving average is $15.97.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.